Website for the Revue de Médecine Vétérinaire
Detail of the article
[Back]
For articles published from January, 2000, you can reach the complete article as a pdf file by clicking on "pdf " in the column "Links" of the table.
| Year : | 2006 |
| Tome : | 157 |
| Volume : | 8-9 |
| Pages : | 431-440 |
| Title : | Comparative palatability of three commercial formulations of carprofen and one commercial formulation of firocoxib in dogs |
| Authors : | M. PAYNE-JOHNSON, T. P. MAITLAND, J. BULLARD and J. GOSSELLIN |
| Summary : | A series of six palatability studies, employing acceptance (three studies) and preference (three studies) tests, were used to compare the voluntary acceptance, preference and consumption of a palatable formulation of carprofen (Rimadyl� Chewable Tablets or Rimadyl� Palatable Tablets; Pfizer Animal Health) with those of two generic formulations of carprofen (Carprodyl� Tablets; Ceva and Norocarp� Tablets; Norbrook) and a formulation of firocoxib (Previcox� Chewable Tablets; M�rial), respectively. All the studies took place at the same kennels and each involved dogs of various and mixed breeds with ages ranging from one to 11 years. Rimadyl� consistently demonstrated significantly better palatability in terms of voluntary choice, prehension and full consumption when compared with each of the other three products Carprodyl�, Norocarp� and Previcox�. |
| Keywords : | palatability, acceptance test, preference test, carprofen, firocoxib, dog |
| Correspondence : | J. GOSSELLIN |
| Adress : | Veterinary Medicine Research and Development, Pfizer Ltd., Ramsgate Road, Sandwich Kent, CT13 9NJ, United Kingdom. E-mail : [email protected] |
| Link : |
[Back]